Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Serotonin Syndrome × telotristat ethyl × NET × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Endocrine 3 NET 2

Conditions

Neuroendocrine Tumors 4 Serotonin Syndrome 2 Pancreatic Neoplasms 1 Neoplasms 1 Diarrhea 1 Carcinoid Tumor 1 Cachexia 1

Interventions

telotristat ethyl 2 lanreotide 1 Random Allocation 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03223428 2024-07-24

RELAX

TerSera Therapeutics LLC

223 enrolled 16 charts

Neuroendocrine Tumors, Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Big Ten Cancer Research Consortium

Phase 2 Withdrawn

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡